Breaking News
Top News
-
Some central banks have been selling their gold. That doesn’t mean you should too.
-
Is it unethical to use AI in my Airbnb photos to market my property to guests?
-
My friends owe me money from 8 months ago—is it too late for me to ask? What etiquette experts say
-
Buffett may end donations to Gates charity over Bill’s ties to Epstein
-
Warsh nomination moves ahead, putting Trump’s competing Fed plans on a collision course
-
‘Unconstrained’ Trump seems to be on a quest to name most everything after himself
-
France to Offer Loans to Small Businesses Hit by Fuel Costs
-
Search for Missing US Airman in Iran
-
Easter Candy Sales Decline
-
Palantir pioneered the hottest job in tech. Its legions of copycats may not succeed.
-
How to Maximize Leverage in Business Deals Without Asking Twice
-
The Iran war is reshaping global aviation
-
Rachel Cruze Tells $14 Million Caller Worried About Awkwardness to Book the Trip
-
TD Cowen Raises its Price Target on Marex Group plc (MRX) to $66 from $61
-
RBC Capital Lowers its Price Target on Bicycle Therapeutics plc (BCYC) to $7 from $11
-
Baird Lowers its Price Target on Nyxoah SA (NYXH) to $4.62 from $5.87
-
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets
-
Mizuho Lowers its Price Target on Autolus Therapeutics plc (AUTL) to $10 from $12
-
Wolfe Research Initiates Coverage of BeOne Medicines AG (ONC) with Outperform Rating
-
Ascendis Pharma A/S (ASND) Reports Positive Week 52 Data from Phase 2 New InsiGHTS Trial
2026-02-05


































